ArticleCureus2026
Percutaneous Thrombectomy for Clot-in-Transit With Concomitant Left Ventricular Thrombus in a Patient With Acute Heart Failure Exacerbation: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clot-in-transit (CIT) is a life-threatening condition in which a venous thrombus is visualized within the right heart while migrating toward the pulmonary arteries. Its coexistence with severe cardiomyopathy and a left ventricular thrombus confers high morbidity and mortality. We report the case of a woman in her 40s with advanced heart failure with reduced ejection fraction (HFrEF), with a left ventricular ejection fraction (LVEF) of 10%-15%, who presented with acute pulmonary embolism (PE) , a large mobile thrombus traversing the tricuspid valve, and an apical left ventricular thrombus, complicated by cardiogenic shock. Given her hemodynamic instability and high surgical risk, she underwent emergent percutaneous aspiration thrombectomy using the FlowTriever device (Inari Medical, Inc., Irvine, CA), achieving successful clot removal and hemodynamic improvement. This case highlights the role of minimally invasive thrombectomy in selected high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.